Innovation and growth are driving strategic buyers in MedTech. Companies are returning to the M&A market with a renewed focus on acquisitions. Mid-market activity will continue to dominate as large companies leverage cash reserves for tuck-in and innovative technology acquisitions.
On the PE-backed side of the M&A market, low-risk medical devices and consumables are gaining prominence. SMEs are well-positioned to capitalise on this trend, offering investors attractive opportunities.
DOWNLOAD THE FULL REPORT BELOW